September 26, 2023
2 mins read

$7.2B by 2029; Psychedelic Market Set to Skyrocket

The ascent is propelled by favourable regulatory developments, including pioneering clinical trial guidelines from the US Food and Drug Administration (FDA)…reports Asian Lite News

The psychedelic drug market is on the brink of extraordinary growth, projected to soar to $7.2 billion by 2029, reflecting a robust 55 per cent compound annual growth rate (CAGR), according to a report on Monday.

This ascent is propelled by favourable regulatory developments, including pioneering clinical trial guidelines from the US Food and Drug Administration (FDA).

These guidelines, crafted in response to promising psychedelic clinical results in mental health disorders, position psychedelics as beacons of hope in the field, revealed the report by GlobalData, a data and analytics company.

Psychedelic drugs, known for their psychoactive properties, stimulate the formation of fresh neural pathways. By targeting serotonin 5-HT2A receptors, they inhibit the default mode network (DMN), responsible for mood and perception, thereby altering conventional thought patterns and potentially offering therapeutic advantages in mental health care.

Promising psychedelics have grappled with clinical trial challenges and FDA approval hurdles due to ambiguous guidelines.

In June 2023, the FDA unveiled draft guidance for conducting psychedelic clinical trials, marking a significant stride toward potential regulatory acceptance in the US. This guidance outlines key considerations in nonclinical, clinical, and safety data, offering insights into the FDA’s forthcoming evaluation of drug applications, anticipated to commence in the near future.

“By 2029, the top three psychedelic drugs — Atai Life Sciences/Otsuka Pharmaceutical’s PCN-101, Cybin’s CYB-003 and Small Pharma’s SPL-026 — are projected to represent 52 per cent of the market’s forecasted sales,” said Kevin Marcaida, Pharma Analyst at GlobalData, in a statement.

PCN-101, a small-molecule drug that is indicated for treatment-resistant depression, is expected to launch in the US in December 2025 and is forecast to generate $1.6 billion in sales in 2029.

CYB-003, a small-molecule drug that is indicated for major depressive disorder, is expected to launch in the US in December 2027 and is forecast to generate $1.4 billion in sales in 2029.

Early detection of Dementia.(photo: IANSLIFE)

SPL-026 is also a small-molecule drug. It is expected to launch in the US in 2027 and in the EU in 2028 and generate $0.9 billion in sales in 2029.

The benefits of psychedelics may go beyond therapeutic applications. According to a study at John Hopkins University, psychedelics are uniquely positioned compared to conventional treatments.

A single psychedelic treatment may offer immediate, cost-effective, and lasting therapeutic benefits for up to one year.

In comparison, conventional treatments such as psychotherapy require several treatments throughout the course of one year alongside specialist support from a medical professional, which is both costly and time-consuming.

“The FDA’s publication of guidance pertaining to psychedelic clinical trials marks a pivotal milestone, emphasising their openness to removing development barriers. This landmark development could galvanise drug development efforts and catalyse further reforms aimed at expediting the psychedelics clinical trial process,” Marcaida said.

ALSO READ: FIRST PERSON: Sukhvinder Gill

Previous Story

Fresh Charge Sheet in 26/11 Terror Case Puts Pressure on Rana

Next Story

Yoon to Mark Historic Visit to the UK

Latest from Business

Microsoft Cuts Deep

The fresh job cuts come less than two months after Microsoft announced it was laying off more than 6,000 employees…reports Asian Lite News Microsoft is set to cut around 9,000 jobs —

Northeast Is Growth Engine

Scindia also provided updates on the government’s efforts to facilitate the entry of SpaceX’s Starlink service into India. “All due diligence from the Ministry’s side is complete Union Minister for Communications and

India to Empower Global South

India is emerging as a pivotal force in the global transition to clean energy, with Union Minister for New and Renewable Energy, Pralhad Joshi, asserting that the country is empowering the Global

Maruti’s Global Push Breaks Record

June shipments hit 37,842 units, signalling robust global demand Maruti Suzuki India recorded its highest-ever monthly exports in June, shipping 37,842 units and marking a new milestone that highlights the company’s expanding

India Bats for Fairer Global Finance: FM Sitharaman

FM Sitharaman stated that we believe that optimal regulation fosters innovation and stability….reports Asian Lite News India supports reforms to the international financial architecture to enhance inclusivity and equity, including Multilateral Development
Go toTop